五级CT算法诊断透明细胞肾细胞癌的外部验证:一项回顾性五读者研究
本研究对2022年提出的用于预测小(cT1a)实性肾肿块是否为透明细胞肾细胞癌(ccRCC)的五级CT算法进行了外部验证。回顾性纳入93例患者共97个小实性肾肿块,由5名读者独立评估皮髓质期CT的肿块-皮质衰减比和异质性评分,计算CT评分。结果显示该算法对ccRCC的汇总敏感度74%、特异度59%、阳性预测值59%、阴性预测值90%,阴性预测值较高,可用于风险分层和主动监测患者选择。
要点
- 五级CT算法在外部样本中对ccRCC的汇总阴性预测值达90%,有助于识别 unlikely 为ccRCC的患者。
- CT评分≤2对乳头状RCC的汇总敏感度44%~100%、特异度77%~98%,但仅9个肿块。
- 读者间一致性:衰减评分中等(AC1=0.70),异质性评分差(AC1=0.17),五级CT评分一般(AC1=0.32)。
局限性
- 回顾性研究设计。
- 单中心样本,样本量较小(97个肿块)。
- 异质性评分读者间一致性差(AC1=0.17),五级CT评分一致性一般(AC1=0.32)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. In 2022, a five-tiered CT algorithm was proposed for predicting whether a small (cT1a) solid renal mass represents clear cell renal cell carcinoma (ccRCC). OBJECTIVE. The purpose of this external validation study was to evaluate the proposed CT algorithm for diagnosis of ccRCC among small solid renal masses. METHODS. This retrospective study included 93 patients (median age, 62 years; 42 women, 51 men) with 97 small solid renal masses that were seen on corticomedullary phase contrast-enhanced CT performed between January 2012 and July 2022 and subsequently underwent surgical resection. Five readers (three attending radiologists, two clinical fellows) independently evaluated masses for the mass-to-cortex corticomedullary attenuation ratio and heterogeneity score; these scores were used to derive the CT score by use of the previously proposed CT algorithm. The CT score's sensitivity, specificity, and PPV for ccRCC were calculated at threshold of 4 or greater, and the NPV for ccRCC was calculated at a threshold of 3 or greater (consistent with thresholds in studies of the MRI-based clear cell likelihood score and the CT algorithm's initial study). The CT score's sensitivity and specificity for papillary RCC were calculated at a threshold of 2 or less. Interreader agreement was assessed using the Gwet agreement coefficient (AC1). RESULTS. Overall, 61 of 97 masses (63%) were malignant and 43 of 97 (44%) were ccRCC. Across readers, CT score had sensitivity ranging from 47% to 95% (pooled sensitivity, 74% [95% CI, 68-80%]), specificity ranging from 19% to 83% (pooled specificity, 59% [95% CI, 52-67%]), PPV ranging from 48% to 76% (pooled PPV, 59% [95% CI, 49-71%]), and NPV ranging from 83% to 100% (pooled NPV, 90% [95% CI, 84-95%]), for ccRCC. A CT score of 2 or less had sensitivity ranging from 44% to 100% and specificity ranging from 77% to 98% for papillary RCC (representing nine of 97 masses). Interreader agreement was substantial for attenuation score (AC1 = 0.70), poor for heterogeneity score (AC1 = 0.17), fair for five-tiered CT score (AC1 = 0.32), and fair for dichotomous CT score at a threshold of 4 or greater (AC1 = 0.24 [95% CI, 0.14-0.33]). CONCLUSION. The five-tiered CT algorithm for evaluation of small solid renal masses was tested in an external sample and showed high NPV for ccRCC. CLINICAL IMPACT. The CT algorithm may be used for risk stratification and patient selection for active surveillance by identifying patients unlikely to have ccRCC.
引用
- Lemieux, Shen, Liang, et al. External Validation of a Five-Tiered CT Algorithm for the Diagnosis of Clear Cell Renal Cell Carcinoma: A Retrospective Five-Reader Study. AJR Am J Roentgenol. 2023. PMID: 37162037. doi:10.2214/AJR.23.29151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。